Integrin-mediated collagen matrix reorganization by cultured human vascular smooth muscle cells

Circulation Research

Volumn 76, Issue 2, 1995, Pages 209-214

  Lee, Richard T ^a,c   Berditchevski, Fedor ^b   Cheng, George C ^a   Hemler, Martin E ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

adhesion; atherosclerosis; collagen; integrins; vascular smooth muscle

Indexed keywords

BLOCKING ANTIBODY; COLLAGEN GEL; INTEGRIN; MONOCLONAL ANTIBODY;

ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CELL ADHESION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE; WOUND HEALING;

EID: 0028955624     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.76.2.209     Document Type: Article

References (45)

1. Sumpio BE, Banes AJ, Link WG, Johnson G Jr. Enhanced collagen production by smooth muscle cells during repetitive mechanical stretching. Arch Surg. 1988;123:1233-1236.
2. Wilson E, Mai Q, Sudhir K, Weiss RH, Ives HE. Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF. J Cell Biol. 1993;123:741-747.
3. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. 1990;15:1667-1687.
4. Casscells W. Migration of smooth muscle and endothelial cells. Circulation. 1992;86:723-729.
5. Davies MJ. A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation. 1990;82(suppl II):II-38-II-46.
6. Fuster V, Badimon L, Badimon JJ, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250.
7. 1, is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils. J Cell Biol. 1991;115:1427-1436.
8. Nakagawa S, Pawelek P, Grinnell F. Long-term culture of fibroblasts in contracted collagen gels: effects on cell growth and biosynthetic activity. J Invest Dermatol. 1989;93:792-798.
9. 1, (VLA-2) mediates reorganization and contraction of collagen matrices by human cells. Cell. 1991;67:403-410.
10. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69:11-25.
11. Hemler ME. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. Annu Rev Immunol. 1990; 8:365-400.
12. Ingber DE. The riddle of morphogenesis: a question of solution chemistry or molecular cell engineering? Cell. 1993;75:1249-1252.
13. 1 integrins from different cell types show different binding specificities. J Biol Chem. 1990;265:615-618.
14. Elices MJ, Hemler ME. The human integrin VLA-2 is a collagen receptor on some cells and a collagen/laminin receptor on others. Proc Natl Acad Sci U S A. 1989;86:9906-9910.
15. 1, integrin in human eye diseases involving vitreoretinal traction. FASEB J. 1993;7:1401-1406.
16. 1 integrin-mediated contraction of collagen gels by cultured retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1994;35:955-963.
17. Chan BMC, Kassner PD, Schiro JA, Byers HR, Kupper TS, Hemler ME. Distinct cellular functions mediated by different VLA integrin α subunit domains. Cell. 1992;68:1051-1060.
18. Clyman RI, McDonald KA, Kramer RH. Integrin receptors on aortic smooth muscle cells mediate adhesion to fibronectin, laminin, and collagen. Circ Res. 1990;67:175-186.
19. 1-like integrin receptor on rat aortic smooth muscle cells mediates adhesion to laminin and collagen types I and IV. Arteriosclerosis. 1990;10: 402-409.
20. 3, integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix. Exp Cell Res. 1992;200:272-284.
21. Akiyama SK, Yamada SS, Chen WT, Yamada KM. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J Cell Biol. 1989;109:863-875.
22. Bank I, Hemler M, Brenner MB, Cohen D, Levy V, Belko J, Crouse C, Chess L. A novel monoclonal antibody. 1B3.1, binds to a new epitope of the VLA-1 molecule. Cell Immunol. 1989;122:416-423.
23. Pischel KD, Hemler ME, Huang C, Bluestein HG, Woods VL. Use of the monoclonal antibody 12F1 to characterize the differentiation antigen VLA-2. J Immunol. 1987;138:226-233.
24. Lemke H, Hammerling GJ, Hohmann C, Rajewsky K. Hybrid cell lines secreting monoclonal antibody specific for major histocompatibility antigens of the mouse. Nature. 1978;271:249-251.
25. Hemler ME, Sanchez-Madrid F, Flotte TJ, Krensky AM, Burakoff SJ, Bhan AK, Springer TA, Strominger JL. Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines. J Immunol. 1984;132:3011-3018.
26. Hemler ME, Huang C, Takada Y, Schwarz L, Strominger JL, Clabby ML. Characterization of the cell surface heterodimer VLA-4 and related peptides. J Biol Chem. 1987;262:11478-11485.
27. Masumoto A, Hemler ME. Multiple activation states of VLA-4. J Biol Chem. 1993;268:228-234.
28. 1 antibody. J Cell Biol. 1993; 120:537-543.
29. Kawaguchi S, Hemler ME. Role of the α subunit cytoplasmic domain in regulation of adhesive activity mediated by the integrin VLA-2. J Biol Chem. 1993;268:16279-16285.
30. Gimbrone MA, Cotran RS. Human vascular smooth muscle in culture. Lab Invest. 1975;33:16-27.
31. Libby P, Warner SK, Friedman GB. Interleukin-1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest. 1988;81:487-498.
32. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb. 1991;11:1223-1230.
33. Karas RH, Petterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation. 1994;89:1943-1950.
34. Hemler ME, Huang C, Schwarz L. The VLA protein family: characterization of five distinct cell surface heterodimers each with a common 130,000 molecular weight β subunit. J Biol Chem. 1987; 262:3300-3309.
35. Schmidt CE, Horwitz AF, Lauffenburger DA, Sheetz MP. Integrin-cytoskeletal interactions in migrating fibroblasts are dynamic, asymmetric, and regulated. J Cell Biol. 1993;123:977-991.
36. Kuijpers TW, Mul EPJ. Blom M, Kovach NL, Gaeta FCA, Tollefson V, Elices MJ, Harlan JM. Freezing adhesion molecules in a state of high-avidity binding blocks eosinophil migration. J Exp Med. 1993;178:279-284.
37. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;262:801-809.
38. Loree HM, Grodzinsky AJ, Park SY, Gibson LJ, Lee RT. Static circumferential tangential modulus of human atherosclerotic tissue. J Biomech. 1994;27:195-204.
39. Cheng GC, Loree HM, Kamm RD, Fishbein MC, Lee RT: Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. Circulation. 1993;87:1179-1187.
40. Campbell JH, Campbell GR. Culture techniques and their applications to studies of vascular smooth muscle. Clin Sci. 1993;85: 501-513.
41. Dilley RJ, McGeachie JK, Prendergast FJ. A review of the proliferative behavior, morphology and phenotypes of vascular smooth muscle. Atherosclerosis. 1987;63:99-107.
42. Koteliansky VE, Belkin AM, Frid MG, Glukhova MA. Developmental changes in expression of adhesion-mediating proteins in human aortic smooth muscle. Biochem Soc Trans. 1991;19: 1072-1076.
43. Belkin VM, Belkin AM, Koteliansky VE. Human smooth muscle VLA-1 integrin: purification, substrate specificity, localization in aorta, and expression during development. J Cell Biol. 1990;111: 2159-2170.
44. Redecker-Beuke B, Thie M, Rauterberg J, Robenek H. Aortic smooth muscle cells in a three-dimensional collagen lattice culture. Arterioscler Thromb. 1993;13:1572-1579.
45. Thie M, Harrach B, Schonherr E, Kresse H, Robenek H, Rauterberg J. Responsiveness of aortic smooth muscle cells to soluble growth mediators is influenced by cell-matrix contact. Arterioscler Thromb. 1993;13:994-1004.